PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS
Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS ...
Biospecimen Management Consortium Accelerates Growth, Releases Landmark Industry Survey, and Launches Key Initiatives
The Biospecimen Management Consortium (BMC), launched in June 2024 to drive sample excellence in clinical research, is pleased to announce significant progress in its mission to revolutionize ...